Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 9 of 662 for:    applied AND web-

Web-based Patient Education Program to Manage Side Effects of Allogeneic Stem Cell Transplant

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02812082
Recruitment Status : Withdrawn (The PI is leaving MSK.)
First Posted : June 23, 2016
Last Update Posted : September 14, 2016
Sponsor:
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

Brief Summary:
The purpose of this study is to develop an interactive web-based patient education program to help educate patients about the increased risk of MS and its cardiac risk factors following allo-SCT and to inform and motivate patients how to make lifestyle changes. This program will be used in addition to counseling at participants clinic visits. The investigators are not changing the recommendations for prevention and management of these conditions, but rather are trying to improve the way they provide this education to patients.

Condition or disease Intervention/treatment Phase
Allo-SCT Patients Adult Allo-SCT Survivor Other: web-based patient education Behavioral: questionnaire Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 0 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Developing and Assessing the Feasibility of Implementing a Video Web-based Patient Education Application
Study Start Date : June 2016
Estimated Primary Completion Date : June 2017

Arm Intervention/treatment
Experimental: video web-based patient education application
This is a single-arm design. Development of the web-based application will occur over a 6 month period. Patient accrual will not occur until development of the program is complete. Controlled usability testing during the development/design process of the computer program will not be employed as we do not aim to assess the mechanics of patient use, but rather overall time spent interacting with the application in an uncontrolled environment. Following completion of the tool, patient accrual will occur over a six month time period in order to meet our target sample size of up to 50 participants. Participants will be directed to complete a pre-test questionnaire at the time of accrual and will have 3 months to use the program before being directed to complete the post-test questionnaire.
Other: web-based patient education
Behavioral: questionnaire



Primary Outcome Measures :
  1. Percentage of patients that use the application [ Time Frame: 1 year ]
    A successful trial will be when ≥ 50% of enrolled patients use the application.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   21 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • The option to participate will be offered to male and female allo-SCT patients at MSK ≥ 21 years of age who are greater than 90 days post-transplant and followed in or referred to the adult allo-SCT survivorship clinic at MSK
  • The option to participate will be offered to male and female allo-SCT patients at MSK ≥ 21 years of age who are greater than 90 days post-transplant and disease free, but have not yet been referred to the survivorship clinic
  • Able to understand written and oral English

Exclusion Criteria:

  • Patients less than 90 days post-transplant
  • Patients without internet access
  • Adult post-transplant patients who have relapsed prior to study recruitment

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02812082


Locations
Layout table for location information
United States, New York
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065
Sponsors and Collaborators
Memorial Sloan Kettering Cancer Center
Investigators
Layout table for investigator information
Principal Investigator: Kara Mosesso, NP Memorial Sloan Kettering Cancer Center

Additional Information:
Layout table for additonal information
Responsible Party: Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT02812082     History of Changes
Other Study ID Numbers: 16-769
First Posted: June 23, 2016    Key Record Dates
Last Update Posted: September 14, 2016
Last Verified: September 2016

Keywords provided by Memorial Sloan Kettering Cancer Center:
Web-based
patient education application
16-769